Champions Oncology, Inc.CSBRNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank80
3Y CAGR-8.2%
5Y CAGR+4.4%
Studio
Year-over-Year Change

Research and development spending

3Y CAGR
-8.2%/yr
vs +24.5%/yr prior
5Y CAGR
+4.4%/yr
Recent deceleration
Acceleration
-32.7pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$8.93M+30.9%
2025$6.83M-28.5%
2024$9.54M-17.3%
2023$11.54M+23.2%
2022$9.37M+30.3%
2021$7.20M+22.9%
2020$5.85M+22.0%
2019$4.80M+9.0%
2018$4.40M+2.5%
2017$4.29M-